Stock listing
NASDAQ:LVTX LAVA Therapeutics NV Stock
Follow LAVA Therapeutics NV into a list and get an email when it puts out news.
Last close · NASDAQ:LVTX
$1.74 USD
Close on Nov 20, 2025 · No longer trades
- Lowest – highest close
- $0.906 – $16.00 USDSince Mar 25, 2021 · lowest Feb 11, 2025 · highest Apr 13, 2021
Delisted NASDAQ:LVTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LVTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
LAVA Therapeutics NV on 6ix
- Decks
- 8 decks · latest Jun 6, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2024) | Investor deck | 28 slides | Jun 6, 2024 |
| Investor Presentation (August 2023) | Investor deck | 43 slides | Aug 15, 2023 |
| Investor Presentation (April 2023) | Investor deck | 45 slides | Apr 24, 2023 |
| Investor Presentation (February 2023) | Investor deck | 46 slides | Feb 16, 2023 |
| Investor Presentation (January 2023) | Investor deck | 40 slides | Jan 9, 2023 |
| Investor Presentation (September 2022) | Investor deck | 35 slides | Sep 30, 2022 |
| Investor Presentation (January 2022) | Investor deck | 40 slides | Jan 7, 2022 |
| Investor Presentation (October 2021) | Investor deck | 41 slides | Oct 13, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christy Oliger Other companies: Zenas BioPharma, Inc. (Director · Since at least Aug 13, 2026); Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); Vera Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Replimune Group, Inc. (Director · Since at least Dec 1, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Aug 28, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past); Reata Pharmaceuticals Inc (Director · Apr 15, 2021 – Sep 26, 2023 · Past) | Director · Since at least Jan 1, 2025 |
| Karen J. Wilson Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Serina Therapeutics, Inc. (Director · Since at least Jan 14, 2025); Elicio Therapeutics, Inc. (Director · Since at least Feb 4, 2021); Vaxart, Inc. (Director · Aug 25, 2020 – Jun 16, 2021 · Past); Jazz Pharmaceuticals plc (SVP, Finance & PAO · Mar 9, 2011 – Mar 5, 2019 · Past) | Director · Since at least Jan 1, 2025 |
| Charles Morris Other companies: Prelude Therapeutics Incorporated (Chief Medical Officer · Since at least Apr 15, 2026); Radius Health, Inc. (Chief Medical Officer · Sep 4, 2018 – Feb 26, 2020 · Past); ImmunoGen Inc (Executive VP & CDO · Nov 26, 2012 – Jul 18, 2016 · Past); Allos Therapeutics Inc (Chief Medical Officer · Apr 26, 2010 – Sep 4, 2012 · Past) | Chief Medical Officer · Jan 1, 2025 – Feb 13, 2025 · Past |
| Jay Backstrom Other companies: Agios Pharmaceuticals, Inc. (Independent Director · Since at least Jul 8, 2025); Disc Medicine, Inc. (Director · Dec 29, 2022 – Dec 29, 2022 · Past); Scholar Rock Holding Corporation (CHIEF EXECUTIVE OFFICER, Director · Sep 20, 2022 – Mar 10, 2025 · Past); Acceleron Pharma Inc (EVP, Research and Development · Dec 10, 2019 – Nov 19, 2021 · Past) | Director · Since at least Jan 1, 2025 |
| Kapil Dhingra Other companies: CARGO Therapeutics, Inc. (Director · Since at least Apr 15, 2024); Black Diamond Therapeutics, Inc. (Director · Since at least Jan 19, 2021); Replimune Group, Inc. (Director · Since at least Jul 19, 2018); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – Apr 16, 2021 · Past) | Director · Since at least Jan 1, 2025 |
| Fred M Powell Other companies: Antares Pharma Inc (Executive Vice President & CFO · Oct 31, 2016 – May 24, 2022 · Past); Celator Pharmaceuticals Inc (VP and Chief Financial Officer · Jan 14, 2013 – Jul 12, 2016 · Past); BMP Sunstone CORP (Chief Financial Officer · Jan 9, 2006 – Feb 24, 2011 · Past) | Chief Financial Officer · Since at least Jan 1, 2025 |
| James Noble Other companies: GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2022 · Past) | Director · Since at least Jan 1, 2025 |
| Stephen A Hurly Other companies: Sesen Bio Inc (President and CEO, Director · Jun 12, 2018 – Jun 12, 2018 · Past); Eleven Biotherapeutics Inc (President and CEO, Director · Sep 20, 2016 – Apr 9, 2018 · Past) | Chief Executive Officer, Director · Since at least Jan 1, 2025 |
| Mary E Wadlinger Other companies: Forma Therapeutics Holdings Inc (See Remarks · Jun 18, 2020 – Feb 23, 2022 · Past) | Director · Since at least Jan 1, 2025 |
| Peter A Kiener Other companies: Cue Biopharma, Inc. (Director · Since at least Jan 2, 2026) | Director · Since at least Nov 13, 2025 |
Log in to ask 6ix AI your own questions about LAVA Therapeutics NV.